APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.
暂无分享,去创建一个
T. Montine | J. Trojanowski | J. Quinn | B. Ritz | S. Factor | D. Weintraub | I. Mata | A. Espay | V. V. Van Deerlin | H. Hurtig | J. Leverenz | S. Rhodes | C. Zabetian | B. Cholerton | A. Peterson | Shu‐Ching Hu | K. Edwards | R. Rausch | Kathryn A. Chung | C. Wood‐Siverio | J. Y. Wan | Johnna Devoto | Frédy J. Revilla
[1] J. Trojanowski,et al. Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations. , 2013, JAMA neurology.
[2] Ralph H. B. Benedict,et al. Hopkins Verbal Learning Test--Revised , 2013 .
[3] Daniel Weintraub,et al. APOE ε4 increases risk for dementia in pure synucleinopathies. , 2013, JAMA neurology.
[4] Keith A. Johnson,et al. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia , 2013, Neurology.
[5] John L. Robinson,et al. Neuropathologic substrates of Parkinson disease dementia , 2012, Annals of neurology.
[6] G. Stebbins,et al. Clinical differences among mild cognitive impairment subtypes in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[7] M. Nalls,et al. A large study reveals no association between APOE and Parkinson's disease , 2012, Neurobiology of Disease.
[8] A. Siderowf,et al. Genetic influences on cognitive decline in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[9] M. Toft,et al. Genetic variability in SNCA and Parkinson’s disease , 2011, neurogenetics.
[10] J. Kulisevsky,et al. Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes. , 2011, Archives of neurology.
[11] K. Hawkins,et al. The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis , 2011, Neurobiology of Aging.
[12] O. Kwon,et al. Apolipoprotein E epsilon 4 allele is not associated with age at onset or MMSE of Parkinson's disease in a Korean study. , 2010, Parkinsonism & related disorders.
[13] K. Hawkins,et al. Verbal Fluency Deficits Co-Occur with Memory Deficits in Geriatric Patients at Risk for Dementia: Implications for the Concept of Mild Cognitive Impairment , 2010, Behavioural neurology.
[14] J. Leverenz,et al. Profile of Cognitive Impairment in Parkinson's Disease , 2010, Brain pathology.
[15] A. Siderowf,et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease , 2009, Neurology.
[16] T. Robbins,et al. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. , 2009, Brain : a journal of neurology.
[17] D. Aarsland,et al. Cognitive impairment in incident, untreated Parkinson disease , 2009, Neurology.
[18] D. Aarsland,et al. APOE Alleles in Parkinson Disease and Their Relationship to Cognitive Decline: A Population-based, Longitudinal Study , 2009, Journal of geriatric psychiatry and neurology.
[19] A. Goris,et al. Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson’s Disease , 2009, Journal of Neurology.
[20] E. Tolosa,et al. Lack of association of APOE and tau polymorphisms with dementia in Parkinson’s disease , 2008, Neuroscience Letters.
[21] G. Halliday,et al. The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years , 2008, Movement disorders : official journal of the Movement Disorder Society.
[22] T. Babić,et al. Is quality of life in non‐demented Parkinson’s disease patients related to cognitive performance? A clinic‐based cross‐sectional study , 2008, European journal of neurology.
[23] J. Nutt,et al. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease , 2007, Annals of neurology.
[24] M. Farrer,et al. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication , 2007, Neurology.
[25] Sophie Schwartz,et al. Role of frontal versus temporal cortex in verbal fluency as revealed by voxel-based lesion symptom mapping , 2006, Journal of the International Neuropsychological Society.
[26] H. Fung,et al. Untangling the tau gene association with neurodegenerative disorders. , 2006, Human molecular genetics.
[27] E. Twamley,et al. Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease , 2006, Journal of the International Neuropsychological Society.
[28] K. Hugdahl,et al. Subtypes of mild cognitive impairment in parkinson's disease: Progression to dementia , 2006, Movement disorders : official journal of the Movement Disorder Society.
[29] K. Murphy,et al. Verbal fluency patterns in amnestic mild cognitive impairment are characteristic of Alzheimer's type dementia , 2006, Journal of the International Neuropsychological Society.
[30] Tatiana Foroud,et al. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia , 2006, Movement disorders : official journal of the Movement Disorder Society.
[31] B. Schmand,et al. Cognitive profile of patients with newly diagnosed Parkinson disease , 2005, Neurology.
[32] Beate Ritz,et al. Clinical characteristics in early Parkinson's disease in a central California population‐based study , 2005, Movement disorders : official journal of the Movement Disorder Society.
[33] J. Cummings,et al. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.
[34] Tore Wentzel-Larsen,et al. The rate of cognitive decline in Parkinson disease. , 2004, Archives of neurology.
[35] Lars Bäckman,et al. Apolipoprotein E and cognitive performance: a meta-analysis. , 2004, Psychology and aging.
[36] D. Aarsland,et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.
[37] K. Marder,et al. The association of incident dementia with mortality in PD , 2002, Neurology.
[38] E. Kaplan,et al. Boston Naming Test , 2001 .
[39] D. Aarsland,et al. Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study , 2000, Journal of the American Geriatrics Society.
[40] D. Aarsland,et al. Mental symptoms in Parkinson's disease are important contributors to caregiver distress , 1999, International journal of geriatric psychiatry.
[41] T. Tombaugh,et al. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. , 1999, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.
[42] J. Haines,et al. Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .
[43] J. Haines,et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.
[44] A. Benton. Contributions to Neuropsychological Assessment: A Clinical Manual , 1983 .
[45] Andrea Klug,et al. Contributions To Neuropsychological Assessment A Clinical Manual , 2016 .
[46] T. Montine,et al. Pacific Northwest Udall Center of excellence clinical consortium: study design and baseline cohort characteristics. , 2013, Journal of Parkinson's disease.
[47] Charles D. Smith,et al. Neuropathologic substrate of mild cognitive impairment. , 2006, Archives of neurology.
[48] D. Finkelhor,et al. ADMINISTRATION AND SCORING MANUAL , 2001 .
[49] R. Monie,et al. Occasional Review , 2022 .